Follicular dendritic cell activation in the Harderian gland of the chicken

1993 ◽  
Vol 35 (3-4) ◽  
pp. 339-351 ◽  
Author(s):  
E. del Cacho ◽  
M. Gallego ◽  
M.A. Marcotegui ◽  
J.A. Bascuas
Immunity ◽  
2017 ◽  
Vol 46 (1) ◽  
pp. 106-119 ◽  
Author(s):  
Abhishek Das ◽  
Balthasar A. Heesters ◽  
Allison Bialas ◽  
Joseph O’Flynn ◽  
Ian R. Rifkin ◽  
...  

1998 ◽  
Vol 6 (1-2) ◽  
pp. 61-70 ◽  
Author(s):  
Yvonne J. Rosenberg ◽  
Mark. G. Lewis ◽  
Marie H. Kosco-Vilbois

Human immunodeficiency virus (HIV) infections have been characterized by both polyclonal Bcell activation and enhanced responsiveness to B-cell growth factors on one hand and the loss of specific antibody (Ab) responses and refractoriness to the normal signals for B-cell activation on the other. Histopathological studies of lymph node from HIV- and simian immunodeficiency virus (SIV)-infected individuals have indicated initial follicular hyperplasia and the appearance of large irregular germinal centers that undergo progressive involution concomitant with follicular dendritic-cell (FDC) disruption. During this process, follicular dendritic-cell -enriched lymph-node-cell cultures exhibit increased ability to induce cluster formation (“in vitrogerminal centers”), lymphocyte proliferation and antibody production compared to uninfected controls. This paper discusses how enhanced FDC-B-cell interaction within SIV-infected germinal centers may result in a reduced ability to select high-affinity B cells and alter the dynamics of antibodyproducing- cell and memory-cell generation resulting in the observed hyperactivity.


Sign in / Sign up

Export Citation Format

Share Document